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Abstract
The current gold standard for the detection of Helicobacter pylori in children remains upper 
endoscopy plus mucosal biopsies. Endoscopy has the advantage of being able to detect 
complications of Helicobacter pylori infection and to rule out other upper gastro-intestinal 
pathologies. An additional advantage of endoscopy with gastric biopsy is that it allows 
physicians to obtain mucosa for urease testing, histological examination and bacterial 
culture. In children, there is a high correlation between antral nodularity at endoscopy 
and the presence of Helicobacter pylori infection. The authors have proposed to investigate 
the correlations between macroscopic aspects during endoscopy and histological find-
ings, in order to identify those endoscopic and histopathological features that can help 
the clinician in clinical practice.
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1. Introduction
Helicobacter pylori (H. pylori) infection is acquired in childhood and remains an important 
cause of peptic ulcer disease (PUD) and gastric cancer. In comparison with adults, children 
and adolescents, however, infrequently develop these complications [1].
It is now well accepted that PUD, the most common stomach disease, is an infectious disease, 
and all consensus conferences agree that the causative agent, H. pylori, must be treated whit 
antibiotics [2].
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
The public health importance of H. pylori discovery, in 1982, and its role in stomach disease 
was recognized in 2005 with the attribution of the Nobel Prize in Medicine to Barry Marshall 
and Robin Warren. H. pylori was classified as a class I human carcinogen by World Health 
Organization in 1994.
Numerous diagnostic tests are available for detecting H. pylori infection: invasive techniques, 
which means endoscopy with biopsies for a rapid urease test (RUT), histology, culture and 
non-invasive techniques, such as serology, 13C-Urea breath test (13C-UBT), and the stool anti-
gen test. There is no single method to detect H. pylori infection reliably and accurately. The 
choice of the diagnostic method depends on patients’ age and complaints, technical difficulty 
level, costs and extensive accessibility in hospitals.
The same diagnostic methods used for adults can be used for children. However, H. pylori 
infection has certain particularities in children which have implications for diagnostic test-
ing. H. pylori infection may slowly establish itself, so it is possible, in rare instances, to find 
the bacteria without traces of inflammation. At endoscopy, antral nodularity is common [2]. 
Histology provides an excellent diagnostic accuracy, allowing for the detection of the bacteria 
as well as for the grading of gastritis. The sensitivity and specificity of histology for the diag-
nosis depends on clinical settings, density of colonization and on pathologist’s experience [3].
2. Material and methods
2.1. Patients
This was a prospective, single center study (in Maria Sklodowska Curie Children’s Emergency 
Hospital Bucharest, Romania) that evaluated consecutive children referred by their physi-
cians for upper endoscopy because of dyspepsia. They were all screened for H. pylori and had 
a positive stool antigen test.
Demographic characteristics and family history of each patient were collected through a ques-
tionnaire, which was completed by parents or by patients depending on the age of the child. 
Demographic data included patients’ age, gender, and residency (urban or country area). 
Information on patient’s history of H. pylori infection as well as on previous therapies was 
obtained. History of siblings or parents infection was also assessed. Patients were asked about 
the time of onset and duration of gastrointestinal symptoms, use of proton pump inhibitors, 
H
2
 receptors antagonists, non steroidal anti-inflammatory drugs or steroidal drugs. Smoking 
status and alcohol consumption was determined as well.
Excluding criteria were: use of proton pump inhibitors or H
2
 receptors antagonists and anti-
biotics as well as non steroidal anti inflammatory drugs or steroidal therapy 2 weeks before 
the beginning of the study, history of intestinal surgery (except for polypectomy and appen-
dectomy), concomitant severe disease (heart, lungs, kidneys and endocrine diseases), and 
smoking and alcohol consumption.
The study was approved by Ethics Committee.
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2.2. Endoscopy
All patients underwent endoscopy with biopsy specimens for histology (one for the antrum, 
one for the corpus). One sample from the antrum was used for rapid urease test. Two addi-
tional biopsies were taken from the antrum for bacterial culture. The samples were placed in 
separates vials, previously identified, containing the appropriate medium for each test.
This procedure was performed in patients with a minimum of 10 hours of fasting, under 
general anesthesia or conscious sedation. Vital signs were continuously monitored for the 
entire procedure.
Written informed consent was obtained from the parent or tutor of each child included in the 
study.
2.3. Histology
A biopsy of gastric body and antrum were fixed in a solution of formaldehyde 10%. 
Subsequently, the gastric mucosa samples were processed, following the usual steps of dehy-
dration and paraffin embedding.
Two stains were used for histological study: hematoxylin eosin and Giemsa. Hematoxylin 
eosin stain was used to evaluate inflammatory cells and H. pylori. Giemsa stain was needed 
when hematoxylin eosin stain failed to identify the bacterium. The Giemsa stain is the pre-
ferred stain for detecting H. pylori because of its technical simplicity, high sensitivity and low 
cost.
Gastritis was graded according to the Sydney System [6] that assesses the severity of inflam-
mation, the level of activity (the degree of polymorph neutrophil inflammation), and the pres-
ence of atrophy and of intestinal metaplasia on a scale from 0 to 3.
In accordance with the Sydney System, the density of H. pylori infection was also semi quan-
titatively classified on a scale from 0 to 3 (mild, moderate, and marked).
H. pylori was recognized in the histological section appearing as a short curved or spiral bacil-
lus resting on the epithelial surface or in the mucus layer.
2.4. Bacterial culture
The biopsy specimens collected for bacterial culture were transported in commercial selective 
transport H. pylori medium, Portagerm pylori (BioMérieux SA, Marcy l’Etoile, France), and 
were inoculated after a few hours onto selective medium Pylori Agar (BioMérieux Italia). 
The plates were incubated under microaerobic condition at 37° for 72 h. Once incubated, 
the colonies resembling H. pylori were identified by Gram stain and by oxidase, catalase and 
urease tests. Suspensions from the primary plates were prepared in sterile solution to perform 
an E-test on Pylori Agar. An agar plate was streaked in three directions with a swab dipped 
into each bacterial suspension to produce a lawn of growth, an E-Test strip (E-Test; AB Bio 
disk, Solna, Sweden) was placed each onto separate plate, which was immediately incubated 
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in a microaerobic atmosphere at 37°C for 72 h. Isolated strains were tested for amoxicillin, 
clarithromycin, metronidazole, and levofloxacin resistance following the recommendations 
of the European Committee on Antimicrobial Susceptibility Testing.
2.5. Statistical analysis
The data was collected and analyzed with Microsoft Excel 2013 and PSPP version 1.0.1. 
Continuous variables with a normal distribution were expressed as a mean with standard 
derivation (SD) and continuous variables with a non-normal distribution as median with 
interquartile range (IQR). Differences between groups were analyzed using Student t-test 
and Mann-Whitney U test for continuous variables, and Fisher’s exact test for categori-
cal variables. A p value <0.05 was considered statistically significant for all the analyzed 
parameters.
3. Results
Of the 38 patients who underwent upper endoscopy with biopsies by protocol (Figure 1), nine 
were excluded because of negative results in both culture and histology.
In the study, the culture and histology examination findings were accepted as “gold stan-
dard”. The detection of H. pylori in at least one of the two tests was accepted as H. pylori posi-
tivity. Negative results in both culture and histology were accepted as H. pylori negativity.
Twenty-nine cases (76.31%) were included in the final analyses, 19 females (65.51%) and the 
10 males (34.49%). The ages were between 3 years and 7 months and 17 years and 8 months 
(mean age 13.5 ± 4.53 years).
Four patients had a family history of peptic ulcer disease. In 15 children the duration of symp-
toms was more than 6 months and 12 patients were previously treated for H. pylori (Table 1).
The mean duration of the period between the onset of symptoms and the effective diagno-
sis in patients with a family history of upper gastrointestinal diseases was 3.75 ± 3.69 and 
8.66 ± 5.42 months in those with negative family history (p = 0.17). A family history of gastric 
or duodenal ulcer did not significantly alter the length of time between the onset of symptoms 
and the diagnosis according to our statistical results, which, however, may have been influ-
enced by the restricted number of patients in our study population.
Twelve patients had previous therapies. The median age of patients who were previously 
treated was 14.5 ± 3.74 and 13 ± 4.71 years old of those without any anterior therapy (p = 0.2).
The most common finding identified at endoscopy was macroscopic nodular antral gastritis, 
which was present in 22 patients (75.86%) (Figure 2). Among these, 10 had additional associ-
ated macroscopic lesions: 8 presented with nodular gastritis of gastric body, 1 with bulbi-
tis, and one with esophagitis. Endoscopy showed antral hyperemia in 4 cases and a normal 
mucosal aspect in other 3 cases (Table 2).
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We tried to find out if there was a significant difference in the severity of endoscopic find-
ings between patients who received previous therapy and those who did not. Among the 12 
previously treated patients, 7 (58.33%) presented with macroscopic nodular antral gastritis, 
Figure 1. Flow chart of the study.
Mean age ± SD, years 13.5 ± 4.47
Male/female 10/29
Familial history for H. pylori infection 4/29
Peptic ulcer/non ulcer dyspepsia 1/28
Previous therapy 12/29
Table 1. Clinical and demographical characteristics of the patients.
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2 (16.67%) with antral hyperemia and 3 (25%) showed a normal mucosal aspect. In patients 
who were not previously treated, we observed macroscopic nodular antral gastritis in 15 cases 
(88.24%), antral hyperemia in 2 cases (11.76%) while a normal appearance of gastric mucosa 
was never detected (Table 3). There was not a statistically significant association between the 
severity of mucosal damage at endoscopy and the existence of a previous therapy against the 
infection (p = 0.06).
In our study, bleeding was the presenting symptom in 4 children; three of them had pan 
gastritis, and one had nodular gastritis and esophagitis.
Figure 2. Endoscopical aspect of Helicobacter pylori gastritis in children (macroscopic nodular antral gastritis).
Endoscopic features n (%)
Macroscopic nodular antral gastritis 22 (75.86%)
Nodular antral gastritis (only) 12
Nodular gastritis of corpus (with) 8
Erosive bulbitis (with) 1
Esophagitis (with) 1
Antral hyperemia without macroscopic nodularity 4 (13.79%)
Normal 3 (10.34)
Total 29 (100%)
Table 2. Endoscopic features associated to Helicobacter pylori infection.
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4. Discussion
There is a clear association between H. pylori and gastritis, gastric ulcer, and duodenal ulcers. 
Studies have shown that this pathogen causes mucosa-associated lymphoid tissue (MALT) 
lymphoma in both children and adults. In fact, when the organism is eradicated, extra gastric 
metastases or sites of MALT lymphoma resolve [4].
The finding of H. pylori-associated gastritis without duodenal or gastric mucosal lesions puts 
the pediatric gastroenterologist in a dilemma on recommending eradication treatment. H. 
pylori-associated gastritis without PUD rarely gives rise of symptoms or progresses to severe 
complications of the disease during childhood [5]. The risk of H. pylori- associated cancer or 
MALT-lymphoma during childhood is extremely low in Europe and North America. Ohno 
reported two cases in Japanese children, a 14-year-old boy and another 6-year-old boy with 
MALT and H. pylori infection [5]. The lower risk of complications in children may be in part 
explained by a different immune response against the infection. In comparison with adults, 
gastric biopsies obtained from children infected with H. pylori show a lower degree of inflamma-
tion. In addition, a higher number of immunosuppressive regulatory T cells and a more promi-
nent IL-10 mediated anti-inflammatory response have been detected in pediatric patients [1].
During childhood, H. pylori is associated with antral predominant gastritis and duodenal 
ulcers [6].
In our study, the most frequent lesion identified by endoscopy was macroscopic antral nodu-
lar gastritis, which was present in 22 patients (78.86%). This high frequency is in accordance 
with a retrospective study from Japan that also found out a marked prevalence of nodular 
antral gastritis associated with H. pylori infection (98.5%) [7]. A nodular antral gastritis fre-
quency of 82.53% was also reported by a Turkish study conducted in adults and adolescents 
Endoscopic features H. pylori infection without 
anterior therapies, n (%)
H. pylori infection with anterior 
therapies, n (%)
Macroscopic nodular antral gastritis 15 (88.24) 7 (58.33%)
Nodular antral gastritis (only) 8 4
Nodular gastritis of corpus (with) 6 2
Erosive bulbitis (with) 0 1
Esophagitis (with) 1 2 (16.67%)
Antral hyperemia without macroscopic 
nodularity
2 (11.76) 3 (25.0%)
Normal 0 12 (100%)
Total 17 (100)
Table 3. Endoscopic features associated to Helicobacter pylori infection: without anterior therapies versus with anterior 
therapies.
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[8]. In a pediatric polish study, the sensitivity of antral nodularity associated with H. pylori 
was 91.6%, and the specificity was 91% [9]. A slightly lower value of specificity of antral nodu-
larity, similar to our results (75.86%), was detected by several authors and ranged from 64 to 
85.2%. Higher specificity was found by others [7–9].
Although the mechanisms underlying nodular gastritis in children is not clear yet, it is 
thought that lymphoid follicles with germinal center form nodules on gastric mucosa or that 
inflammatory reaction generated by H. pylori infection results in an exaggerated appearance 
of a normal gastric mucosa [10].
In a 14-year-old boy we observed erosions at endoscopy. The frequency of these lesions in our 
study (3.45%) is similar to the one measured by another study conducted in Italy (3.40%) [11].
A prospective study, carried out during 1-month simultaneously in 19 centers among 14 
European countries, showed a frequency of 8.1% of ulcers and/or erosions in children, occur-
ring mainly in the second decade of life, but H. pylori infection and toxic gastric medications 
were less frequently implicated than expected in their development. On a total of 56 children 
with ulcers or erosions, H. pylori was present in 15 patients (27%), 8 used NSAIDs, 5 were 
treated with steroids, 5 with immune-suppressive drugs, 6 with antibiotics, 1 with antacids, 6 
with H
2
 blockers and 8 with proton pump inhibitors (more than one risk factor was detected 
in 32 of 56 children) [12].
For years, reports have noted an association between peptic ulcer disease and families with a 
strong history of upper gastrointestinal tract disease, in particular between gastric and duo-
denal ulcers. Family history of gastric cancer is an important component in the diagnosis 
and management of H. pylori infection in children. Children with a mother or a father with 
gastric cancer are considered to be at very high risk owing to shared genetic characteristics, 
environmental factors, and virulence features of the infecting strain of H. pylori [4].
In countries with an elevated risk for gastric cancer, however, eradicating H. pylori in child-
hood could be more effective in preventing gastric atrophy, and ultimately, cancer develop-
ment [13]. It still remains to be determined whether H. pylori-infected children with gastric 
atrophy are at increased risk for gastric cancer [14].
Recently, a decreasing proportion of H. pylori-positive peptic ulcers in adults has been 
observed, along with a decrease in the prevalence of infection, while, on the other hand, an 
increasing number of patients that use non-steroidal anti-inflammatory drugs (NSAIDs) has 
been noted [7, 15]. Regarding children, there are a few available data in the literature that 
investigate the trend of H. pylori prevalence in peptic ulcer [16].
In our study, four patients had a family history of H. pylori infection, none of gastric cancer, 
two of peptic ulcer, and two of H. pylori chronic gastritis. In this situation, the period of the 
onset of symptoms and to presentation to the doctor was less than 3 months, so that the aver-
age duration of symptoms are 3.75 ± 3.69 months in comparison with 8.66 ± 5.42 months for 
those without family history for gastric or duodenal ulcers. Influence of family history for 
upper gastrointestinal tract diseases to the period of the onset of symptoms and diagnosis, 
can be explained by the consciousness of the disease and the risks than derive from it.
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The sex difference between the H. pylori-positive and H. pylori-negative group is also of great 
interest. We found female preponderance in the study group (65.51%), similarly with another 
report in our geographic area (78.49%) [17].
Studies have unanimously shown a male preponderance for peptic ulcer disease in children. 
It is still not known why primary peptic ulcers predominantly develop in infected male chil-
dren. Epidemiological studies do not suggest any sex predilection in H. pylori infection [16].
Median age for patients with previous therapies was 14.5 ± 3.74 years, comparative with 
13 ± 4.71 years for patients without previous therapies, results or else expected. We do 
not have data to express if it is failure of antimicrobial therapy or reinfection. 1/12 patient 
with previous therapies had family history of peptic ulcer disease. We do not investigate 
all the family member of each child, and therefore we do not know the real status of H. 
pylori infection. Familial history for gastrointestinal disease was collected for interview. 
Magistà et al. [18] identified two variables by logistic regression analysis as predictors of 
H. pylori reinfection: age of primary infection and having an infected sibling. Multivariable 
analysis revealed that only age at primary infection correlates with an increased risk of 
reinfection [18].
In patients with anterior therapies, the endoscopic features were less serious than in those 
without any previous treatment. All three patients with normal endoscopic mucosa were 
anteriorly treated. These results suggest that children might become “tolerant” to the bacte-
rium or that the growing child is more resistant to H. pylori-induced lesions. The evidence that 
H. pylori infection in children coexist with normal gastric mucosa was reported in a percent 
comparable with our results (11%) [19]. This is the reason for which we strongly recommend 
to take biopsies at least for histological exam in children and adolescents, even if a normal 
appearance of mucosa is observed during endoscopy.
The ability of H. pylori to manipulate the immune response (activation or inactivation of 
Toll-like receptors dependent response) may be responsible for bacterial survival and a mild 
course of infection in children [20].
5. Conclusions
The main endoscopic feature found in our study was macroscopic nodular antral gastritis, 
in 75.86%. In 10.34% of cases the endoscopic aspect of mucosa was normal. All patients with 
normal endoscopic mucosa were previously treated. These results suggest that children 
might become “tolerant” to the bacterium or that the growing child is more resistant to H. 
pylori-induced lesions.
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